NPI | Name | Type | Address |
---|---|---|---|
Salma Afifi |
Individual |
1275 York Ave New York, NY |
|
DR. PHARM.D. Ryan Daley |
Individual |
1275 York Ave Schwartz Building, S-714 New York, NY |
|
MS. PHARMD Mabel Rodriguez |
Individual |
1275 York Ave New York, NY |
|
PHARMD Kefei Dai |
Individual |
1275 York Ave Bldg S-710 New York, NY |
|
RPH Dina Boulos |
Individual |
160 E 53rd St New York, NY |
|
PHARMD Meagan Barbee |
Individual |
1275 York Ave Schwartz 714 New York, NY |
|
DR. PHARMD Anthony Joseph Proli II |
Individual |
1233 York Ave Rm 307 New York, NY |
|
PHARM.D. Joshua Pecoraro |
Individual |
1275 York Ave S-714 New York, NY |
|
DR. PHARMD Qiong Yan |
Individual |
1275 York Ave Schwartz 710 New York, NY |
|
DR. PHARMD Lisa Modelevsky |
Individual |
1275 York Ave New York, NY |
|
Peter Sullivan |
Individual |
1275 York Ave New York, NY |
|
PHARMD Adebayo Ogunniyi |
Individual |
1275 York Ave S-710 New York, NY |
|
DR. Amber Courtney King |
Individual |
1250 1st Ave S-710 New York, NY |
|
DR. PHARM.D., BCOP Larry Wayne Buie |
Individual |
1275 York Ave 1275 York Avenue New York, NY |
|
DR. PHARMD Sherry Mathew |
Individual |
1250 1st Ave Dept Of Pharmacy Schwartz Bldg New York, NY |
|
Margaret Puchaev |
Individual |
560 1st Ave New York, NY |
|
Mei-ting Wong |
Individual |
New York University Langone Medical Center 550 1st Ave New York, NY |
|
Julia Choi |
Individual |
160 E 53rd St New York, NY |
|
PHARMD Laura Tang |
Individual |
1275 York Ave New York, NY |
|
DR. PHARMD Josiah David Land |
Individual |
1275 York Ave New York, NY |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |